J Chem Inf Model - Jointly handling potency and toxicity of antimicrobial peptidomimetics by simple rules from desirability theory and chemoinformatics.

Tópicos

{ compound(1573) activ(1297) structur(1058) }
{ system(1976) rule(880) can(841) }
{ model(2656) set(1616) predict(1553) }
{ drug(1928) target(777) effect(648) }
{ featur(3375) classif(2383) classifi(1994) }
{ cancer(2502) breast(956) screen(824) }
{ implement(1333) system(1263) develop(1122) }
{ problem(2511) optim(1539) algorithm(950) }
{ perform(1367) use(1326) method(1137) }
{ high(1669) rate(1365) level(1280) }
{ measur(2081) correl(1212) valu(896) }
{ learn(2355) train(1041) set(1003) }
{ method(1557) propos(1049) approach(1037) }
{ data(2317) use(1299) case(1017) }
{ can(774) often(719) complex(702) }
{ imag(1057) registr(996) error(939) }
{ framework(1458) process(801) describ(734) }
{ clinic(1479) use(1117) guidelin(835) }
{ extract(1171) text(1153) clinic(932) }
{ data(1714) softwar(1251) tool(1186) }
{ general(901) number(790) one(736) }
{ case(1353) use(1143) diagnosi(1136) }
{ import(1318) role(1303) understand(862) }
{ state(1844) use(1261) util(961) }
{ gene(2352) biolog(1181) express(1162) }
{ decis(3086) make(1611) patient(1517) }
{ model(3404) distribut(989) bayesian(671) }
{ take(945) account(800) differ(722) }
{ motion(1329) object(1292) video(1091) }
{ assess(1506) score(1403) qualiti(1306) }
{ chang(1828) time(1643) increas(1301) }
{ model(2220) cell(1177) simul(1124) }
{ howev(809) still(633) remain(590) }
{ model(2341) predict(2261) use(1141) }
{ visual(1396) interact(850) tool(830) }
{ blood(1257) pressur(1144) flow(957) }
{ health(3367) inform(1360) care(1135) }
{ monitor(1329) mobil(1314) devic(1160) }
{ age(1611) year(1155) adult(843) }
{ medic(1828) order(1363) alert(1069) }
{ data(3008) multipl(1320) sourc(1022) }
{ first(2504) two(1366) second(1323) }
{ time(1939) patient(1703) rate(768) }
{ can(981) present(881) function(850) }
{ use(976) code(926) identifi(902) }
{ activ(1452) weight(1219) physic(1104) }
{ method(1969) cluster(1462) data(1082) }
{ imag(1947) propos(1133) code(1026) }
{ data(1737) use(1416) pattern(1282) }
{ inform(2794) health(2639) internet(1427) }
{ bind(1733) structur(1185) ligand(1036) }
{ sequenc(1873) structur(1644) protein(1328) }
{ method(1219) similar(1157) match(930) }
{ imag(2830) propos(1344) filter(1198) }
{ network(2748) neural(1063) input(814) }
{ imag(2675) segment(2577) method(1081) }
{ patient(2315) diseas(1263) diabet(1191) }
{ studi(2440) review(1878) systemat(933) }
{ treatment(1704) effect(941) patient(846) }
{ surgeri(1148) surgic(1085) robot(1054) }
{ error(1145) method(1030) estim(1020) }
{ concept(1167) ontolog(924) domain(897) }
{ algorithm(1844) comput(1787) effici(935) }
{ design(1359) user(1324) use(1319) }
{ control(1307) perform(991) simul(935) }
{ care(1570) inform(1187) nurs(1089) }
{ method(984) reconstruct(947) comput(926) }
{ search(2224) databas(1162) retriev(909) }
{ featur(1941) imag(1645) propos(1176) }
{ data(3963) clinic(1234) research(1004) }
{ studi(1410) differ(1259) use(1210) }
{ risk(3053) factor(974) diseas(938) }
{ perform(999) metric(946) measur(919) }
{ research(1085) discuss(1038) issu(1018) }
{ system(1050) medic(1026) inform(1018) }
{ studi(1119) effect(1106) posit(819) }
{ spatial(1525) area(1432) region(1030) }
{ record(1888) medic(1808) patient(1693) }
{ model(3480) simul(1196) paramet(876) }
{ ehr(2073) health(1662) electron(1139) }
{ research(1218) medic(880) student(794) }
{ patient(2837) hospit(1953) medic(668) }
{ signal(2180) analysi(812) frequenc(800) }
{ cost(1906) reduc(1198) effect(832) }
{ group(2977) signific(1463) compar(1072) }
{ sampl(1606) size(1419) use(1276) }
{ intervent(3218) particip(2042) group(1664) }
{ activ(1138) subject(705) human(624) }
{ patient(1821) servic(1111) care(1106) }
{ use(2086) technolog(871) perceiv(783) }
{ analysi(2126) use(1163) compon(1037) }
{ health(1844) social(1437) communiti(874) }
{ structur(1116) can(940) graph(676) }
{ use(1733) differ(960) four(931) }
{ result(1111) use(1088) new(759) }
{ survey(1388) particip(1329) question(1065) }
{ estim(2440) model(1874) function(577) }
{ process(1125) use(805) approach(778) }
{ method(2212) result(1239) propos(1039) }
{ detect(2391) sensit(1101) algorithm(908) }

Resumo

Today, emerging and increasing resistance to antibiotics has become a threat to public health worldwide. Antimicrobial peptides have unique action mechanisms making them an attractive therapeutic prospect to be applied against resistant bacteria. However, the major drawback is related with their high hemolytic activity which cancels out the safety requirements for a human antibiotic. Therefore, additional efforts are needed to develop new antimicrobial peptides that possess a greater potency for bacterial cells and less or no toxicity over erythrocytes. In this paper, we introduce a practical approach to simultaneously deal with these two conflicting properties. The convergence of machine learning techniques and desirability theory allowed us to derive a simple, predictive, and interpretable multicriteria classification rule for simultaneously handling the antibacterial and hemolytic properties of a set of cyclic ?-hairpin cationic peptidomimetics (C?-HCPs). The multicriteria classification rule exhibited a prediction accuracy of about 80% on training and external validation sets. Results from an additional concordance test have shown an excellent agreement between the multicriteria classification rule predictions and the predictions from independent classifiers for complementary antibacterial and hemolytic activities, respectively, evidencing the reliability of the multicriteria classification rule. The rule was also consistent with the general mode of action of cationic peptides pointing out its biophysical relevance. We also propose a multicriteria virtual screening strategy based on the joint use of the multicriteria classification rule, desirability, similarity, and chemometrics concepts. The ability of such a virtual screening strategy to prioritize selective (nonhemolytic) antibacterial C?-HCPs was assessed and challenged for their predictivity regarding the training, validation, and overall data. In doing so, we were able to rank a selective antibacterial C?-HCP earlier than a biologically inactive or nonselective antibacterial C?-HCP with a probability of ca. 0.9. Our results thus indicate that promising chemoinformatics tools were obtained by considering both the multicriteria classification rule and the virtual screening strategy, which could, for instance, be used to aid the discovery and development of potent and nontoxic antimicrobial peptides.

Resumo Limpo

today emerg increas resist antibiot becom threat public health worldwid antimicrobi peptid uniqu action mechan make attract therapeut prospect appli resist bacteria howev major drawback relat high hemolyt activ cancel safeti requir human antibiot therefor addit effort need develop new antimicrobi peptid possess greater potenc bacteri cell less toxic erythrocyt paper introduc practic approach simultan deal two conflict properti converg machin learn techniqu desir theori allow us deriv simpl predict interpret multicriteria classif rule simultan handl antibacteri hemolyt properti set cyclic hairpin cation peptidomimet chcps multicriteria classif rule exhibit predict accuraci train extern valid set result addit concord test shown excel agreement multicriteria classif rule predict predict independ classifi complementari antibacteri hemolyt activ respect evidenc reliabl multicriteria classif rule rule also consist general mode action cation peptid point biophys relev also propos multicriteria virtual screen strategi base joint use multicriteria classif rule desir similar chemometr concept abil virtual screen strategi priorit select nonhemolyt antibacteri chcps assess challeng predict regard train valid overal data abl rank select antibacteri chcp earlier biolog inact nonselect antibacteri chcp probabl ca result thus indic promis chemoinformat tool obtain consid multicriteria classif rule virtual screen strategi instanc use aid discoveri develop potent nontox antimicrobi peptid

Resumos Similares

J Chem Inf Model - Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods. ( 0,826619434378411 )
J Chem Inf Model - Hsp90 inhibitors, part 2: combining ligand-based and structure-based approaches for virtual screening application. ( 0,809167955425386 )
J Chem Inf Model - Predictions of BuChE inhibitors using support vector machine and naive Bayesian classification techniques in drug discovery. ( 0,805555738766365 )
J Chem Inf Model - Discovering new agents active against methicillin-resistant Staphylococcus aureus with ligand-based approaches. ( 0,78770966931955 )
J Chem Inf Model - Structure based model for the prediction of phospholipidosis induction potential of small molecules. ( 0,780128224160881 )
J Chem Inf Model - Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity. ( 0,778561774799516 )
J Chem Inf Model - Coping with unbalanced class data sets in oral absorption models. ( 0,773520620105699 )
J Chem Inf Model - QSAR classification model for antibacterial compounds and its use in virtual screening. ( 0,771722757093874 )
J Chem Inf Model - Predictive models for cytochrome p450 isozymes based on quantitative high throughput screening data. ( 0,768404602275763 )
J Chem Inf Model - A new protocol for predicting novel GSK-3? ATP competitive inhibitors. ( 0,764689287300962 )
J Chem Inf Model - Predicting myelosuppression of drugs from in silico models. ( 0,764580718918278 )
J Chem Inf Model - Modeling drug-induced anorexia by molecular topology. ( 0,760433674902032 )
J Chem Inf Model - Profile-QSAR and Surrogate AutoShim protein-family modeling of proteases. ( 0,759717841483367 )
J Chem Inf Model - Exploring the biologically relevant chemical space for drug discovery. ( 0,750565254295394 )
J Chem Inf Model - Automated recycling of chemistry for virtual screening and library design. ( 0,749337199703298 )
J Chem Inf Model - Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. ( 0,745939562700656 )
J Am Med Inform Assoc - Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds. ( 0,742751341859053 )
J Chem Inf Model - Oversampling to overcome overfitting: exploring the relationship between data set composition, molecular descriptors, and predictive modeling methods. ( 0,742057216702508 )
J Chem Inf Model - Compound set enrichment: a novel approach to analysis of primary HTS data. ( 0,741130038556148 )
J Chem Inf Model - Development of a rule-based method for the assessment of protein druggability. ( 0,741118885794413 )
J Chem Inf Model - Discovery and design of tricyclic scaffolds as protein kinase CK2 (CK2) inhibitors through a combination of shape-based virtual screening and structure-based molecular modification. ( 0,739293994365189 )
J Chem Inf Model - Construction and use of fragment-augmented molecular Hasse diagrams. ( 0,737156456613164 )
J Chem Inf Model - Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery. ( 0,735828682688695 )
J Integr Bioinform - Database supported candidate search for metabolite identification. ( 0,730966565133557 )
J Chem Inf Model - ColBioS-FlavRC: a collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes. ( 0,728276773845549 )
J Chem Inf Model - Hsp90 inhibitors, part 1: definition of 3-D QSAutogrid/R models as a tool for virtual screening. ( 0,726890373827278 )
J Chem Inf Model - Visual characterization and diversity quantification of chemical libraries: 1. creation of delimited reference chemical subspaces. ( 0,726060908165797 )
J Chem Inf Model - Computational repositioning and experimental validation of approved drugs for HIF-prolyl hydroxylase inhibition. ( 0,725945715518006 )
J Chem Inf Model - Target-independent prediction of drug synergies using only drug lipophilicity. ( 0,723005414106501 )
J Chem Inf Model - Design and synthesis of new antioxidants predicted by the model developed on a set of pulvinic acid derivatives. ( 0,720711338183528 )
J Chem Inf Model - Development of dimethyl sulfoxide solubility models using 163,000 molecules: using a domain applicability metric to select more reliable predictions. ( 0,714236226696647 )
J Chem Inf Model - Chemical data visualization and analysis with incremental generative topographic mapping: big data challenge. ( 0,712170303844721 )
J Chem Inf Model - TIN-a combinatorial compound collection of synthetically feasible multicomponent synthesis products. ( 0,711857765267713 )
J Chem Inf Model - ZINClick: a database of 16 million novel, patentable, and readily synthesizable 1,4-disubstituted triazoles. ( 0,710072962160717 )
J Chem Inf Model - Discovery of a7-nicotinic receptor ligands by virtual screening of the chemical universe database GDB-13. ( 0,709533269929377 )
J Chem Inf Model - Application of quantitative structure-activity relationship models of 5-HT1A receptor binding to virtual screening identifies novel and potent 5-HT1A ligands. ( 0,709343068112204 )
J Chem Inf Model - Fragment-based lead discovery and design. ( 0,708721666168905 )
J Chem Inf Model - A multivariate chemical similarity approach to search for drugs of potential environmental concern. ( 0,70861860186731 )
J Chem Inf Model - Similarity boosted quantitative structure-activity relationship--a systematic study of enhancing structural descriptors by molecular similarity. ( 0,704367765439307 )
J Chem Inf Model - Characterizing the diversity and biological relevance of the MLPCN assay manifold and screening set. ( 0,704154339142587 )
J Chem Inf Model - Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation. ( 0,704046946324097 )
J Chem Inf Model - SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition. ( 0,70356224080302 )
J Chem Inf Model - A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition. ( 0,702904172559002 )
J Chem Inf Model - Identification of novel malarial cysteine protease inhibitors using structure-based virtual screening of a focused cysteine protease inhibitor library. ( 0,701885275424981 )
J Chem Inf Model - Statistical analysis and compound selection of combinatorial libraries for soluble epoxide hydrolase. ( 0,701873669984777 )
J Chem Inf Model - Structural similarity based kriging for quantitative structure activity and property relationship modeling. ( 0,70055549413088 )
J Chem Inf Model - Prediction of activity cliffs using support vector machines. ( 0,700087985057019 )
J Chem Inf Model - Mining chemical reactions using neighborhood behavior and condensed graphs of reactions approaches. ( 0,699904512130896 )
J Chem Inf Model - Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal. ( 0,699062073642556 )
J Chem Inf Model - Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors. ( 0,697755322423887 )
J Chem Inf Model - G-protein coupled receptors virtual screening using genetic algorithm focused chemical space. ( 0,695201029498698 )
J Chem Inf Model - How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space. ( 0,694747295336771 )
J Chem Inf Model - Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. ( 0,694291608704801 )
J Chem Inf Model - Classification of compounds with distinct or overlapping multi-target activities and diverse molecular mechanisms using emerging chemical patterns. ( 0,692666232176994 )
J Chem Inf Model - Accurate atom-mapping computation for biochemical reactions. ( 0,689974464028045 )
J Chem Inf Model - Polypharmacology directed compound data mining: identification of promiscuous chemotypes with different activity profiles and comparison to approved drugs. ( 0,689254985523497 )
Curr Comput Aided Drug Des - Development of Chemical Compound Libraries for In Silico Drug Screening. ( 0,689162453868681 )
J Chem Inf Model - Conditional probabilistic analysis for prediction of the activity landscape and relative compound activities. ( 0,689063459906713 )
J Chem Inf Model - Combining horizontal and vertical substructure relationships in scaffold hierarchies for activity prediction. ( 0,687922182365626 )
J Chem Inf Model - Application of the 4D fingerprint method with a robust scoring function for scaffold-hopping and drug repurposing strategies. ( 0,687648950870467 )
J Chem Inf Model - Identification of 1,2,5-oxadiazoles as a new class of SENP2 inhibitors using structure based virtual screening. ( 0,687600077084319 )
J Chem Inf Model - Probing the bioactivity-relevant chemical space of robust reactions and common molecular building blocks. ( 0,685558917021822 )
J Chem Inf Model - Optimization of molecular representativeness. ( 0,685327032169294 )
J Chem Inf Model - Identification of multitarget activity ridges in high-dimensional bioactivity spaces. ( 0,685222707738078 )
J Chem Inf Model - Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area. ( 0,685008677673678 )
J Chem Inf Model - Design of multitarget activity landscapes that capture hierarchical activity cliff distributions. ( 0,684814348630631 )
J Chem Inf Model - Natural product-like virtual libraries: recursive atom-based enumeration. ( 0,683823529411765 )
J Chem Inf Model - Synthesis, bioassay, and molecular field topology analysis of diverse vasodilatory heterocycles. ( 0,68381572058855 )
J Chem Inf Model - BioSM: metabolomics tool for identifying endogenous mammalian biochemical structures in chemical structure space. ( 0,68294481855591 )
J Chem Inf Model - Compound pathway model to capture SAR progression: comparison of activity cliff-dependent and -independent pathways. ( 0,681525106352096 )
J Chem Inf Model - Bioturbo similarity searching: combining chemical and biological similarity to discover structurally diverse bioactive molecules. ( 0,681518766927644 )
J Chem Inf Model - De novo design of drug-like molecules by a fragment-based molecular evolutionary approach. ( 0,681144935709653 )
J Chem Inf Model - Virtual screening yields inhibitors of novel antifungal drug target, benzoate 4-monooxygenase. ( 0,681046010686513 )
J Chem Inf Model - ToxAlerts: a Web server of structural alerts for toxic chemicals and compounds with potential adverse reactions. ( 0,679711530604258 )
J Integr Bioinform - Identifying interactions between chemical entities in biomedical text. ( 0,679482381250278 )
J Chem Inf Model - Harvesting classification trees for drug discovery. ( 0,67936800517175 )
J Chem Inf Model - In silico prediction of total human plasma clearance. ( 0,67927412905534 )
J Chem Inf Model - Rationalizing the role of SAR tolerance for ligand-based virtual screening. ( 0,678824923543105 )
J Chem Inf Model - Identification of novel potential antibiotics against Staphylococcus using structure-based drug screening targeting dihydrofolate reductase. ( 0,677336344300608 )
J Chem Inf Model - Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screening. ( 0,677309155335931 )
J Chem Inf Model - Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17. ( 0,677303933185748 )
J Chem Inf Model - In silico enzymatic synthesis of a 400,000 compound biochemical database for nontargeted metabolomics. ( 0,677027337263546 )
J Chem Inf Model - Capturing structure-activity relationships from chemogenomic spaces. ( 0,676876998958789 )
J Chem Inf Model - Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations. ( 0,676742610878188 )
J Chem Inf Model - Freely available conformer generation methods: how good are they? ( 0,676565748222531 )
J Chem Inf Model - Development of Ecom50 and retention index models for nontargeted metabolomics: identification of 1,3-dicyclohexylurea in human serum by HPLC/mass spectrometry. ( 0,676296191157912 )
J Chem Inf Model - Identification of novel serotonin transporter compounds by virtual screening. ( 0,676161137041976 )
J Chem Inf Model - Mining electronic laboratory notebooks: analysis, retrosynthesis, and reaction based enumeration. ( 0,675212920452503 )
J Chem Inf Model - Identification of novel liver X receptor activators by structure-based modeling. ( 0,674870229740221 )
J Chem Inf Model - From activity cliffs to activity ridges: informative data structures for SAR analysis. ( 0,673590737225381 )
J Chem Inf Model - Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution. ( 0,671573421261714 )
J Chem Inf Model - Visualization and virtual screening of the chemical universe database GDB-17. ( 0,671085173364156 )
J Chem Inf Model - Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. ( 0,670747080367764 )
J Chem Inf Model - Design of a three-dimensional multitarget activity landscape. ( 0,670427220250494 )
J Chem Inf Model - In silico assessment of chemical biodegradability. ( 0,669656975544671 )
J Chem Inf Model - Compound optimization through data set-dependent chemical transformations. ( 0,669618324079111 )
J Chem Inf Model - Prediction of individual compounds forming activity cliffs using emerging chemical patterns. ( 0,669032626528091 )
J Chem Inf Model - GA(M)E-QSAR: a novel, fully automatic genetic-algorithm-(meta)-ensembles approach for binary classification in ligand-based drug design. ( 0,667802426548645 )
J Chem Inf Model - Novel mycosin protease MycP1 inhibitors identified by virtual screening and 4D fingerprints. ( 0,667749498682881 )
J Chem Inf Model - Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library. ( 0,667739065473051 )